You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TNF alpha antagonists

Showing 1 - 25 of 6,721
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sarcoidosis Trial (STOP arm)

Not yet recruiting
  • Sarcoidosis
  • STOP arm
  • (no location specified)
Jan 16, 2023

Tumor Necrosis Factor-alpha Antagonists in Rheumatoid Arthritis.

Recruiting
  • Rheumatoid Arthritis
  • +2 more
  • Infliximab: Adalimumab; Etanercept;
  • Sulaymaniyah, Kurdistan Region, Iraq
    Hiwa Khidhir Saaed
May 12, 2022

HLA-DQA1*05 Genotype in Anti-TNF Treatment With Proactive

Recruiting
  • Drug Monitoring
  • Inflammatory Bowel Diseases
  • Tumor necrosis factor (TNF)-alpha inhibitors
  • Valladolid, Spain
    Hospital Universitario Rio Hortega
Aug 8, 2023

Pneumococcal Vaccination in Patients With Anti-TNF Alpha Therapy

Not yet recruiting
  • Pneumococcal Vaccine
  • Pneumococcal vaccine
  • Pontoise, France
    Internal Medicine Department - NOVO Hospital - Pontoise site
Mar 28, 2023

Lung Transplant; Complications Trial in Chicago (Etanercept Injection [Enbrel])

Enrolling by invitation
  • Lung Transplant; Complications
  • Etanercept Injection [Enbrel]
  • Chicago, Illinois
    Northwestern University
Jul 10, 2023

Spondyloarthritis, Crohn Disease, Ulcerative Colitis Trial in Pessac (blood sample, stool samples, food questionnaire)

Completed
  • Spondyloarthritis
  • +2 more
  • blood sample
  • +4 more
  • Pessac, France
    CHU de Bordeaux - service d'Hépato-gastroentérologie
May 25, 2022

IL-17, TNF-alpha, RANKL Levels in Gingival Cervicular Fluid

Not yet recruiting
  • Apical Periodontitis
  • The teeth diagnosed with chronic apical periodontitis
  • (no location specified)
Feb 1, 2022

Failure to Thrive, Infection, Bacterial, Growth Faltering Trial in Surabaya (high calorie formula (oral nutritional

Recruiting
  • Failure to Thrive
  • +2 more
  • high calorie formula (oral nutritional supplement/ONS)
  • Surabaya, East Java, Indonesia
    Husada Utama Hospital
Oct 2, 2022

HIV Trial in Honolulu, New York, Cleveland (Tumor Necrosis Factor soluble receptor-immunoadhesin complex)

Completed
  • HIV Infections
  • Tumor Necrosis Factor soluble receptor-immunoadhesin complex
  • Honolulu, Hawaii
  • +2 more
Oct 28, 2021

Ustekinumab in Active Crohn's Disease

Completed
  • Crohn Disease
  • Evaluation of biological predictive factors of clinical response to ustekinumab
  • Pierre-Bénite, France
    Centre hospitalier Lyon Sud
Aug 23, 2022

Periimplant Soft Tissue Phenotype on Marginal Bone Loss

Completed
  • Alveolar Bone Loss
  • +2 more
  • Nuclear Factor-Kappa B Ligand (RANKL) analysis
  • +4 more
  • Konya, Turkey
    Necmettin Erbakan University, dentistry Faculty
Jan 24, 2023

Rheumatoid Arthritis Trial in Canada, United States (ISIS 104838)

Completed
  • Rheumatoid Arthritis
  • ISIS 104838
  • Birmingham, Alabama
  • +30 more
Dec 1, 2022

Rates of Dementia and Alzheimer's Disease in Participants

Completed
  • Dementia
  • Alzheimer Disease
  • Titusville, New Jersey
    Janssen R&D
Oct 15, 2021

Long-term Outcome of TNF Alpha Therapy in IBD

Completed
  • IBD
  • TNF Alpha therapy
  • Graz, Austria
    Medical University of Graz
Feb 23, 2021

Rheumatic Diseases, Mood Disorders Trial in Besançon (Blood sample)

Recruiting
  • Rheumatic Diseases
  • Mood Disorders
  • Blood sample
  • Besançon, France
    University Hospital
Apr 5, 2022

Evaluation of New Biomarkers in Stage 3 and 4 Endometriosis

Completed
  • Endometriosis
  • endometriosis surgery
  • other benign condition surgeries
  • Istanbul, Bagcilar, Turkey
    Bagcilar Teaching and Research Hospital
Mar 26, 2022

Predictors of Prognosis in IBD Patients

Recruiting
  • Inflammatory Bowel Diseases
  • +2 more
  • Endoscopic biopsy
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
    Seoul National University Bundang Hospital
Dec 7, 2022

Juvenile Idiopathic Arthritis Associated Uveitis Trial in Cairo (biologic DMARDs)

Active, not recruiting
  • Juvenile Idiopathic Arthritis Associated Uveitis
  • biologic DMARDs
  • Cairo, Egypt
    Faculty of medicine, Cairo university
Sep 12, 2022

Glioma of Brain Trial in Bern, Lausanne, Zürich (L19TNF)

Active, not recruiting
  • Glioma of Brain
  • Bern, Switzerland
  • +2 more
Apr 7, 2022

PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, Subclinical hypothyroïdism, Hypothalamic-Pituitary-Gonadal Axis

Not yet recruiting
  • PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
  • +2 more
  • Measurement and comparison of leucocytosis and concentrations of CRP, procalcitonin, fibrinogen, ferritin, IL-1, IL-6, IL-10, TNF-alpha in both study arms
  • +2 more
  • Kraków, Poland
    Jagiellonian University Medical College, Department of Gynecolog
Apr 29, 2023

Bypass Complication, Cardioplegia Solution Adverse Reaction, Endothelial Degeneration Trial in Istanbul (Endocan, E-Selectin,

Active, not recruiting
  • Bypass Complication
  • +5 more
  • Endocan, E-Selectin, TNF-alpha, Total Oxidant and Antioxidant Status
  • Istanbul, Turkey
    Dr. Siyami Ersek Hospital
Oct 28, 2022

CharacterisatiON of carDiac funCTion in Intensive Care Unit

Not yet recruiting
  • Heart Failure
  • +3 more
  • CMR
  • +7 more
  • Glasgow, United Kingdom
  • +1 more
Nov 21, 2022

Colitis,Ulcerative Trial in Norway (Discontinuation of anti-TNF treatment, Continuation of anti-TNF treatment)

Active, not recruiting
  • Colitis,Ulcerative
  • Discontinuation of anti-TNF treatment
  • Continuation of anti-TNF treatment
  • Alesund, Norway
  • +18 more
Jul 13, 2022

Plaque Psoriasis Trial in Beijing (HLX03, adalimumab)

Completed
  • Plaque Psoriasis
  • Beijing, China
    Peking University People's Hospital
May 4, 2022

Rheumatoid Arthritis (RA) Trial in Pittsburgh (TNF Antagonist (enbrel, humire, remicade, cimzia, symponi), Abatacept,

Terminated
Has Results
  • Rheumatoid Arthritis (RA)
  • TNF Antagonist (enbrel, humire, remicade, cimzia, symponi)
  • +2 more
  • Pittsburgh, Pennsylvania
    University of Pittsburgh
Sep 9, 2020